Education
About Us
Working with TipRanks
Follow Us
ROBERTO MIGNONE Insider Profile
4 Followers
ROBERTO MIGNONE, Director at Teva Pharmaceutical, holds 472.92K shares in Teva Pharmaceutical (Ticker: TEVA), holds 3.43K shares in Guardant Health (Ticker: GH). Most recently, ROBERTO MIGNONE Sold ― shares of Teva Pharmaceutical on Dec 18, 2025 for an estimated value of $2.34M.
Profitable Transactions
0 out of 6 Profitable Transactions
Average Return
-16.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that ROBERTO MIGNONE holds in companies
Most Profitable Insider Trade
The most profitable trade made by ROBERTO MIGNONE
ROBERTO MIGNONE's Trading History
Teva Pharmaceutical
Dec 18, 2025
Director
Informative Sell
2.34M
$14.35M
Guardant Health
Nov 24, 2025
Director
Uninformative Buy
27.83K
$342.21K
List of latest transactions for each holding click on a transaction to see ROBERTO MIGNONE's performance on stock
You May Also Like
ROBERTO MIGNONE insider profile FAQ
What is the percentage of profitable transactions made by ROBERTO MIGNONE?
The percentage of profitable transactions made by ROBERTO MIGNONE is 0%.
What is the average return per transaction made by ROBERTO MIGNONE?
The average return per transaction made by ROBERTO MIGNONE is -16.30%.
What stocks does ROBERTO MIGNONE hold?
ROBERTO MIGNONE holds: TEVA, GH stocks.
What was ROBERTO MIGNONE’s latest transaction?
ROBERTO MIGNONE latest transaction was an Informative Sell of $2.34M.
What was ROBERTO MIGNONE's most profitable transaction?
ROBERTO MIGNONE’s most profitable transaction was an Informative Sell of TEVA stock on June 21, 2024. The return on the trade was 0.00%.
What is ROBERTO MIGNONE's role in Teva Pharmaceutical?
ROBERTO MIGNONE's role in Teva Pharmaceutical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.